首页> 外国专利> DOSING REGIMEN FOR LH(LUTEINIZING HORMONE) OR HCG(HUMAN CHORIONIC GONADOTROPIN) AND EPO(ERYTHROPOIETIN)FOR TREATING NEURODEGENERATIVE DISEASE

DOSING REGIMEN FOR LH(LUTEINIZING HORMONE) OR HCG(HUMAN CHORIONIC GONADOTROPIN) AND EPO(ERYTHROPOIETIN)FOR TREATING NEURODEGENERATIVE DISEASE

机译:用于治疗LH(人类激素)或HCG(人绒毛膜促性腺激素)和EPO(促红细胞生成素)的药物治疗神经退行性疾病

摘要

PPROBLEM TO BE SOLVED: To provide dosing regimens effective for neural stem cell proliferating agents and neural stem cell differentiating agents, to provide a kit including the regimens, and to provide uses of the kit. PSOLUTION: The dosing regimens effective for neural stem cell proliferating agents and neural stem cell differentiating agents, the kit including the regimens, and uses of the kit, are provided. Such a kit or method may treat neurodegenerative diseases or conditions through short-term or long-term uses. Further, related compositions and methods may continuously or intermittently use for various kinds of regimens. In particular, the thus provided kit is intended for treating or ameliorating neurodegenerative diseases or conditions in mammals and includes EPO and at least 3 dose-units of hCG or LH. PCOPYRIGHT: (C)2010,JPO&INPIT
机译:

要解决的问题:提供对神经干细胞增殖剂和神经干细胞分化剂有效的给药方案,提供包括该方案的试剂盒,并提供该试剂盒的用途。

解决方案:提供了对神经干细胞增殖剂和神经干细胞分化剂有效的给药方案,包括该方案的试剂盒以及该试剂盒的用途。这样的试剂盒或方法可以通过短期或长期使用来治疗神经退行性疾病或病症。此外,相关的组合物和方法可以连续或间断地用于各种方案。特别地,如此提供的试剂盒旨在用于治疗或改善哺乳动物的神经退行性疾病或病症,并且包括EPO和hCG或LH的至少3个剂量单位。

版权:(C)2010,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号